Characterization of a New Virus-neutralizing Epitope that Denotes a Sequential Determinant on the Rabies Virus Glycoprotein

References

1. Bos E. S., Van Der doelen A. A., Van Rooij M., Schuurs A. H. W. M. 1981; 3,3′,5,5′-Tetramethyl-benzidine as an Ames test negative chromogen for horseradish peroxidase in enzyme immunoassay. Journal of Immunoassay 2:187–204
   [Google Scholar]
2. Cox J. H., Dietzschold B., Schneider L. G. 1977; Rabies virus glycoprotein. II. Biological and serological characterization. Infection and Immunity 16:754–759
   [Google Scholar]
3. Dietzschold B., Wiktor T. J., Macfarlan R., Varrichio A. 1982; Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments. Journal of Virology 44:595–602
   [Google Scholar]
4. Dietzschold B., Wiktor T. J., Wunner W. H., Varrichio A. 1983; Chemical and immunological analysis of the rabies virus soluble glycoprotein. Virology 14:330–337
   [Google Scholar]
5. Dietzschold B., Lafon M., Wang H., Otvos L. JR, Celis E., Wunner W. H., Koprowski H. 1987a; Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins. Virus Research 8:103–125
   [Google Scholar]
6. Dietzschold B., Tollis M., Rupprecht C. E., celis E., Koprowski H. 1987b; Antigenic variation in rabies and rabies-related viruses. Cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. Journal of Infectious Diseases 156:815–822
   [Google Scholar]
7. Flamand A., Wiktor T.J., Koprowski H. 1980; Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. Journal of General Virology 48:105–109
   [Google Scholar]
8. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. 1979; A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. Journal of Immunology 123:1548–1550
   [Google Scholar]
9. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
   [Google Scholar]
10. Lafon M., Wiktor T.J., Macfarlan R. I. 1983; Antigenic sites on the CVS rabies virus glycoprotein. Analysis with monoclonal antibodies. Journal of General Virology 64:843–851
    [Google Scholar]
11. Lafon M., Ideler I., Wunner W.H. 1984; Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Developments in Biological Standardization 57:219–225
    [Google Scholar]
12. Macfarlan R. I., Dietzschold B., Wiktor T. J., Kiel M., Houghten R., Lerner R. A., Sutcliffe I. G., Koprowski H. 1984; T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. Journal of Immunology 133:2748–2752
    [Google Scholar]
13. Nakane P. K., Kawaoi A. 1974; Peroxidase-labeled antibody. A new method of conjugation. Journal of Histochemistry and Cytochemistry 22:1084–1091
    [Google Scholar]
14. Osterhaus A. D. M. E., Van Wezel A. L., Van Steenis G., Hazendonk A. G., Drost G. A. 1982; Production and potential use of monoclonal antibodies against polioviruses. Developments in Biological Standardization 50:221–223
    [Google Scholar]
15. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of SciencesU.S.A. 76:4350–4354
    [Google Scholar]
16. Turner G. C. 1985; Immune response after rabies vaccination. Basic aspects. Annales de l’Institut Pasteur/Virologie 136E:453–160
    [Google Scholar]
17. Van Wezel A. L., Van Steenis g., Hannik C. A., Cohen H. 1978; New approaches to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Developments in Biological Standardization 41:159–168
    [Google Scholar]
18. Wiktor T.J., Koprowski H. 1978; Monoclonal antibodies against rabies virus produced by somatic cellhybridization: detection of antigenic variants. Proceedings of the National Academy of SciencesU.S.A. 75:3938–3942
    [Google Scholar]
19. Wiktor T. J., Koprowski H. 1980; Antigenic variants of rabies virus. Journal of Experimental Medicine 152:99–112
    [Google Scholar]
20. Wiktor T. J., Gyorgy E., Schlumberger H.D., Sokol F., Koprowski H. 1973; Antigenic properties of rabies virus components. Journal of Immunology 110:269–276
    [Google Scholar]
21. Wiktor T. J., Kamo I., Koprowski H. 1974; In vitro stimulation of rabbit lymphocytes after immunization with live and inactivated rabies vaccines. Journal of Immunology 112:2013–2019
    [Google Scholar]
22. Wiktor T. J., Doherty P. C., Koprowski H. 1977; In vitro evidence of cell mediated immunity after exposure of mice to both live and inactivated rabies virus. Proceedings of the National Academy of SciencesU.S.A. 74:334–338
    [Google Scholar]
23. Wiktor T. J., Macfarlan R. I., Reagan K., Dietzschold B., Curtis P., Wunner W. H., Kieny M. P., Lathe R., Lecocq I. P., Mackett M., Moss B., Koprowski H. 1984; Protection from rabies by vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of SciencesU.S.A. 81:7194–7198
    [Google Scholar]
24. Wunner W. H., Dietzschold B., Macfarlan R. I., Smith C. L., Golub E., Wiktor T. J. 1985; Localization of immunogenic domains on the rabies virus glycoprotein. Annales de l’Institut Pasteurj Virologie 136E:353–362
    [Google Scholar]